483 Roundup: FDA Cites Five Drugmakers for GMPs, Other Issues

Drug GMP Report
A A
The FDA hammered five drug manufacturers — one Indian and four American — for varying issues at their drug making facilities, sending the companies Form 483s for their violations.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $200.00